Helicobacter pylori: a clinician's view.
Helicobacter pylori infection has been linked with a number of gastrointestinal diseases, such as peptic ulcer disease, gastric mucosa-associated lymphoid tissue lymphoma and gastric cancer. This article reviews some of the evidence for these associations, and discusses the latest recommended indications for eradication therapy.
Gibbons
A H
AH
Hinchingbrooke Health Care NHS Trust, Hinchingbrooke Hospital, Cambridgeshire PE29 6NT.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001284:Atrophy; D004415:Dyspepsia / Q000382:microbiology; D005764:Gastroesophageal Reflux / Q000382:microbiology; D005767:Gastrointestinal Diseases / Q000382:microbiology*; D016481:Helicobacter Infections / Q000150:complications*; D016480:Helicobacter pylori; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000382:microbiology; D010437:Peptic Ulcer / Q000382:microbiology; D013270:Stomach / Q000473:pathology; D013274:Stomach Neoplasms / Q000382:microbiology
D000894:Anti-Inflammatory Agents, Non-Steroidal